Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Diabetes/Metabolism Research and Reviews|July 17, 2007
The age at diagnosis of type 1 diabetes continues to decrease in Belgian boys but not in girls: a 15-year surveyI Weets, R Rooman, M Coeckelberghs, et al.
Diabetologia|March 10, 2005
Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetesK Decochez, I Truyen, B van der Auwera, et al.
Pancreas|May 1, 1996
Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Belgian Diabetes RegistryC Semakula, C L Vandewalle, C F Van Schravendijk, et al.
Diabetologia|December 19, 2002
IA-2 autoantibodies predict impending type I diabetes in siblings of patientsK Decochez, I H De Leeuw, B Keymeulen, et al.
Diabetologia|March 30, 2006
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetesI Weets, I Truyen, I Verschraegen, et al.
Diabetes Care|October 7, 1997
Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes RegistryC L Vandewalle, A Falorni, A Lernmark, et al.
Diabetologia|November 10, 2009
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patientsE Vandemeulebroucke, B Keymeulen, K Decochez, et al.
Diabetes Care|August 11, 2000
Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes RegistryK Decochez, B Keymeulen, G Somers, et al.
Diabetologia|August 10, 2004
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidenceI Weets, L Kaufman, B Van der Auwera, et al.
Biochemical Pharmacology|March 7, 2001
Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5Y Zambre, Z Ling, M C Chen, et al.
Pageof 12